Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis

Research output: Contribution to journalJournal articleResearchpeer-review

  • Gabriella Galatà
  • Andrés C. García-Montero
  • Thomas Kristensen
  • Ahmed A.Z. Dawoud
  • Javier I. Muñoz-González
  • Manja Meggendorfer
  • Paola Guglielmelli
  • Yvette Hoade
  • Ivan Alvarez-Twose
  • Christian Gieger
  • Konstantin Strauch
  • Luigi Ferrucci
  • Toshiko Tanaka
  • Stefania Bandinelli
  • Theresia M. Schnurr
  • Torsten Haferlach
  • Sigurd Broesby-Olsen
  • Hanne Vestergaard
  • Michael Boe Møller
  • Carsten Bindslev-Jensen
  • And 7 others
  • Alessandro M. Vannucchi
  • Alberto Orfao
  • Deepti Radia
  • Andreas Reiter
  • Andrew J. Chase
  • Nicholas C.P. Cross
  • William J. Tapper

Mastocytosis is a rare myeloid neoplasm characterized by uncontrolled expansion of mast cells, driven in >80% of affected individuals by acquisition of the KIT D816V mutation. To explore the hypothesis that inherited variation predisposes to mastocytosis, we performed a two-stage genome-wide association study, analyzing 1,035 individuals with KIT D816V positive disease and 17,960 healthy control individuals from five European populations. After quality control, we tested 592,007 SNPs at stage 1 and 75 SNPs at stage 2 for association by using logistic regression and performed a fixed effects meta-analysis to combine evidence across the two stages. From the meta-analysis, we identified three intergenic SNPs associated with mastocytosis that achieved genome-wide significance without heterogeneity between cohorts: rs4616402 (pmeta = 1.37 × 10−15, OR = 1.52), rs4662380 (pmeta = 2.11 × 10−12, OR = 1.46), and rs13077541 (pmeta = 2.10 × 10−9, OR = 1.33). Expression quantitative trait analyses demonstrated that rs4616402 is associated with the expression of CEBPA (peQTL = 2.3 × 10−14), a gene encoding a transcription factor known to play a critical role in myelopoiesis. The role of the other two SNPs is less clear: rs4662380 is associated with expression of the long non-coding RNA gene TEX41 (peQTL = 2.55 × 10−11), whereas rs13077541 is associated with the expression of TBL1XR1, which encodes transducin (β)-like 1 X-linked receptor 1 (peQTL = 5.70 × 10−8). In individuals with available data and non-advanced disease, rs4616402 was associated with age at presentation (p = 0.009; beta = 4.41; n = 422). Additional focused analysis identified suggestive associations between mastocytosis and genetic variation at TERT, TPSAB1/TPSB2, and IL13. These findings demonstrate that multiple germline variants predispose to KIT D816V positive mastocytosis and provide novel avenues for functional investigation.

Original languageEnglish
JournalAmerican Journal of Human Genetics
Volume108
Issue number2
Pages (from-to)284-294
Number of pages11
ISSN0002-9297
DOIs
Publication statusPublished - 2021

    Research areas

  • CEBPA, D816V, KIT, mastocytosis, myeloid cancer, TBL1XR1, TERT

ID: 260033069